Literature DB >> 32197258

Angular distribution of neutron production by proton and carbon-ion therapeutic beams.

Jianxin Zhou1, Angela Di Fulvio2, Kyle Beyer3, Michele Ferrarini4, Marco Pullia4, Marco Donetti4, Shaun D Clarke5, Sara A Pozzi3.   

Abstract

Carbon-ion beams are increasingly used in the clinical practice for external radiotherapy treatments of deep-seated tumors. At therapeutic energies, carbon ions yield significant secondary products, including neutrons, which may be concerning for the radiation protection of the patient and personnel. We simulated the neutron yield produced by protons and carbon-ion pencil beams impinging on a clinical phantom at three different angles: 15o, 45o, and 90o, with respect to the beam axis. We validated the simulated results using the measured response of organic scintillation detectors. We compared the results obtained with FLUKA 2011.2 and MCNPX 2.7.0 based on three different physics models: Bertini, Isabel, and CEM. Over the different ions, energies, and angles, the FLUKA simulation results agree better with the measured data, compared to the MCNPX results. Simulations of carbon ions at low angles exhibit both the highest deviation from measured data and inter-model discrepancy, which is probably due to the different treatment of the pre-equilibrium stage. The reported neutron yield results could help in the comparison of carbon-ion and proton treatments in terms of secondary neutron production for radiation protection applications.
© 2020 Institute of Physics and Engineering in Medicine.

Entities:  

Keywords:  Hadron therapy; Monte Carlo simulations; Organic scintillators

Year:  2020        PMID: 32197258     DOI: 10.1088/1361-6560/ab81ca

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  The influence of beam delivery uncertainty on dose uniformity and penumbra for pencil beam scanning in carbon-ion radiotherapy.

Authors:  Yue Li; Yunzhe Gao; Xinguo Liu; Jian Shi; Jiawen Xia; Jiancheng Yang; Lijun Mao
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.